Novel malaria vaccine reaches next phase

Sauerwein Robert

Professor of Medical Parasitology, Robert Sauerwein, has received a grant of $ 3.4 million from the Bill & Melinda Gates Foundation to further the development of a vaccine that provides effective protection against malaria.

The Sauerwein group has published about a breakthrough in vaccine research in top journals such as the New England Journal of Medicine, The Lancet and PNAS. These results were the reason for the Bill & Melinda Gates Foundation to award his group $ 3.4 million to further the clinical investigation of the vaccine. The grant will be used to study mechanism of protection in malaria infection and thereby further develop vaccines in a targeted, rational way. Furthermore, the effect of the vaccine has only been tested with a particular parasite strain. In nature, many different strains occur with different genetic variations. Therefore, we proposes to investigate whether the protection witnessed also occurs with infection by various other strains. If that is the case, then the application of the vaccine is another important step closer.

<< back to overview news items